Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features.

IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Journal of gastrointestinal oncology Pub Date : 2025-02-28 Epub Date: 2025-02-26 DOI:10.21037/jgo-2024-931
Yongfei He, Qiang Gao, Shutian Mo, Ketuan Huang, Yuan Liao, Tianyi Liang, Meifeng Chen, Jicai Wang, Qiang Tao, Guangquan Zhang, Fenfang Wu, Chuangye Han, Xianjie Shi, Tao Peng
{"title":"Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features.","authors":"Yongfei He, Qiang Gao, Shutian Mo, Ketuan Huang, Yuan Liao, Tianyi Liang, Meifeng Chen, Jicai Wang, Qiang Tao, Guangquan Zhang, Fenfang Wu, Chuangye Han, Xianjie Shi, Tao Peng","doi":"10.21037/jgo-2024-931","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Portal hypertension (PHT) is an important factor leading to a poor prognosis in patients with hepatocellular carcinoma (HCC). Identifying patients with PHT for individualized treatment is of great clinical significance. The prediction model of HCC combined PHT is in urgent need of clinical practice. Combining clinical parameters and imaging features can improve prediction accuracy. The application of artificial intelligence algorithms can further tap the potential of data, optimize the prediction model, and provide strong support for early intervention and personalized treatment of PHT. This study aimed to establish a prediction model of PHT based on the clinicopathological features of PHT and computed tomography scanning features of the non-tumor liver area in the portal vein stage.</p><p><strong>Methods: </strong>A total of 884 patients were enrolled in this study, and randomly divided into a training set of 707 patients (of whom 89 had PHT) and a validation set of 177 patients (of whom 23 had PHT) at a ratio of 8:2. Univariate and multivariate logistic regression analyses were performed to screen the clinical features. Radiomics and deep-learning features were extracted from the non-tumorous liver regions. Feature selection was conducted using <i>t</i>-tests, correlation analyses, and least absolute shrinkage and selection operator regression models. Finally, a predictive model for PHT in HCC patients was constructed by combining clinical features with the selected radiomics and deep-learning features.</p><p><strong>Results: </strong>Portal vein diameter (PVD), Child-Pugh score, and fibrosis 4 (FIB-4) score were identified as independent risk factors for PHT. The predictive model that incorporated clinical features, radiomics features from non-tumorous liver regions, and deep-learning features had an area under the curve (AUC) of 0.966 [95% confidence interval (CI): 0.954-0.979] and a sensitivity of 0.966 in the training set, and an AUC of 0.698 (95% CI: 0.565-0.831) and a sensitivity of 0.609 in the validation set.</p><p><strong>Conclusions: </strong>The preoperative evaluation showed that increased PVD, higher Child-Pugh score, and increased FIB-4 score were independent risk factors for PHT in patients with HCC. To predict the occurrence of PHT more effectively, we construct a comprehensive prediction model. The model incorporates clinical parameters, radiomic features, and deep learning features. This fusion of multi-modal features enables the model to capture complex information related to PHT more comprehensively, thus achieving high prediction accuracy and practicability.</p>","PeriodicalId":15841,"journal":{"name":"Journal of gastrointestinal oncology","volume":"16 1","pages":"159-175"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11921233/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastrointestinal oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jgo-2024-931","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Portal hypertension (PHT) is an important factor leading to a poor prognosis in patients with hepatocellular carcinoma (HCC). Identifying patients with PHT for individualized treatment is of great clinical significance. The prediction model of HCC combined PHT is in urgent need of clinical practice. Combining clinical parameters and imaging features can improve prediction accuracy. The application of artificial intelligence algorithms can further tap the potential of data, optimize the prediction model, and provide strong support for early intervention and personalized treatment of PHT. This study aimed to establish a prediction model of PHT based on the clinicopathological features of PHT and computed tomography scanning features of the non-tumor liver area in the portal vein stage.

Methods: A total of 884 patients were enrolled in this study, and randomly divided into a training set of 707 patients (of whom 89 had PHT) and a validation set of 177 patients (of whom 23 had PHT) at a ratio of 8:2. Univariate and multivariate logistic regression analyses were performed to screen the clinical features. Radiomics and deep-learning features were extracted from the non-tumorous liver regions. Feature selection was conducted using t-tests, correlation analyses, and least absolute shrinkage and selection operator regression models. Finally, a predictive model for PHT in HCC patients was constructed by combining clinical features with the selected radiomics and deep-learning features.

Results: Portal vein diameter (PVD), Child-Pugh score, and fibrosis 4 (FIB-4) score were identified as independent risk factors for PHT. The predictive model that incorporated clinical features, radiomics features from non-tumorous liver regions, and deep-learning features had an area under the curve (AUC) of 0.966 [95% confidence interval (CI): 0.954-0.979] and a sensitivity of 0.966 in the training set, and an AUC of 0.698 (95% CI: 0.565-0.831) and a sensitivity of 0.609 in the validation set.

Conclusions: The preoperative evaluation showed that increased PVD, higher Child-Pugh score, and increased FIB-4 score were independent risk factors for PHT in patients with HCC. To predict the occurrence of PHT more effectively, we construct a comprehensive prediction model. The model incorporates clinical parameters, radiomic features, and deep learning features. This fusion of multi-modal features enables the model to capture complex information related to PHT more comprehensively, thus achieving high prediction accuracy and practicability.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
根据临床参数和影像学特征,采用人工智能算法建立并验证了肝癌门静脉高压的预测模型。
背景:门脉高压(PHT)是导致肝细胞癌(HCC)患者预后不良的重要因素。识别PHT患者进行个体化治疗具有重要的临床意义。HCC联合PHT的预测模型是临床急需的。结合临床参数和影像学特征可提高预测准确率。人工智能算法的应用可以进一步挖掘数据潜力,优化预测模型,为PHT的早期干预和个性化治疗提供有力支持。本研究旨在根据PHT的临床病理特征和门静脉期非肿瘤肝区ct扫描特征,建立PHT的预测模型。方法:本研究共纳入884例患者,按8:2的比例随机分为训练组707例(其中PHT 89例)和验证组177例(其中PHT 23例)。采用单因素和多因素logistic回归分析筛选临床特征。从非肿瘤肝脏区域提取放射组学和深度学习特征。使用t检验、相关分析、最小绝对收缩和选择算子回归模型进行特征选择。最后,将临床特征与选择的放射组学和深度学习特征相结合,构建HCC患者PHT的预测模型。结果:门静脉直径(PVD)、Child-Pugh评分和纤维化4 (FIB-4)评分被确定为PHT的独立危险因素。结合临床特征、非肿瘤肝区放射组学特征和深度学习特征的预测模型,在训练集中的曲线下面积(AUC)为0.966[95%置信区间(CI): 0.954-0.979],灵敏度为0.966,在验证集中的AUC为0.698 (95% CI: 0.565-0.831),灵敏度为0.609。结论:术前评估显示PVD增高、Child-Pugh评分增高、FIB-4评分增高是HCC患者发生PHT的独立危险因素。为了更有效地预测PHT的发生,我们构建了一个综合预测模型。该模型结合了临床参数、放射学特征和深度学习特征。这种多模态特征的融合使模型能够更全面地捕获与PHT相关的复杂信息,从而达到较高的预测精度和实用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.20
自引率
0.00%
发文量
171
期刊介绍: ournal of Gastrointestinal Oncology (Print ISSN 2078-6891; Online ISSN 2219-679X; J Gastrointest Oncol; JGO), the official journal of Society for Gastrointestinal Oncology (SGO), is an open-access, international peer-reviewed journal. It is published quarterly (Sep. 2010- Dec. 2013), bimonthly (Feb. 2014 -) and openly distributed worldwide. JGO publishes manuscripts that focus on updated and practical information about diagnosis, prevention and clinical investigations of gastrointestinal cancer treatment. Specific areas of interest include, but not limited to, multimodality therapy, markers, imaging and tumor biology.
期刊最新文献
Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis. Claudin 18.2 in gastroesophageal adenocarcinoma: prevalence, biomarker associations, and implications for equity. Erratum: The clinical value of spectral computed tomography reconstruction technology for the anatomy of the superior mesenteric artery in laparoscopic radical right hemicolectomy for colon cancer: a cross-sectional study. Bibliometric analysis on the correlation between colorectal cancer and tumor microenvironment [2009-2024]. First-line PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for advanced esophageal and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1